323 related articles for article (PubMed ID: 23221385)
1. Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma.
Mertens JC; Fingas CD; Christensen JD; Smoot RL; Bronk SF; Werneburg NW; Gustafson MP; Dietz AB; Roberts LR; Sirica AE; Gores GJ
Cancer Res; 2013 Jan; 73(2):897-907. PubMed ID: 23221385
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis.
Ilyas SI; Mertens JC; Bronk SF; Hirsova P; Dai H; Roberts LR; Kaufmann SH; Gores GJ
J Biol Chem; 2014 Aug; 289(33):22835-22849. PubMed ID: 24973208
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.
Cadamuro M; Brivio S; Mertens J; Vismara M; Moncsek A; Milani C; Fingas C; Cristina Malerba M; Nardo G; Dall'Olmo L; Milani E; Mariotti V; Stecca T; Massani M; Spirli C; Fiorotto R; Indraccolo S; Strazzabosco M; Fabris L
J Hepatol; 2019 Apr; 70(4):700-709. PubMed ID: 30553841
[TBL] [Abstract][Full Text] [Related]
4. Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis.
Lagares D; Santos A; Grasberger PE; Liu F; Probst CK; Rahimi RA; Sakai N; Kuehl T; Ryan J; Bhola P; Montero J; Kapoor M; Baron M; Varelas X; Tschumperlin DJ; Letai A; Tager AM
Sci Transl Med; 2017 Dec; 9(420):. PubMed ID: 29237758
[TBL] [Abstract][Full Text] [Related]
5. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase.
Lin Y; Cai Q; Chen Y; Shi T; Liu W; Mao L; Deng B; Ying Z; Gao Y; Luo H; Yang X; Huang X; Shi Y; He R
Hepatology; 2022 Jan; 75(1):28-42. PubMed ID: 34387870
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
Ravichandra A; Bhattacharjee S; Affò S
Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
[TBL] [Abstract][Full Text] [Related]
7. SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment.
Czekay RP; Higgins CE; Aydin HB; Samarakoon R; Subasi NB; Higgins SP; Lee H; Higgins PJ
Cells; 2024 May; 13(10):. PubMed ID: 38786020
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation.
Zhang Z; Lai GH; Sirica AE
Hepatology; 2004 Apr; 39(4):1028-37. PubMed ID: 15057907
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
Kim JH; Liu L; Lee SO; Kim YT; You KR; Kim DG
Cancer Res; 2005 Jul; 65(14):6312-20. PubMed ID: 16024633
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of BH3 mimetics as a combination therapy with irradiation in head and neck squamous cell carcinoma.
Korelin K; Oostveen M; Wahbi W; Ianevski F; Cavalcante B; Turunen L; Belevich I; Al-Samadi A; Salo T
Biomed Pharmacother; 2024 Jun; 175():116719. PubMed ID: 38749173
[TBL] [Abstract][Full Text] [Related]
11. A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts.
Chen B; Wang Z; Sun J; Song Q; He B; Zhang H; Wang X; Dai W; Zhang Q
Nanomedicine; 2016 Jan; 12(1):131-41. PubMed ID: 26518604
[TBL] [Abstract][Full Text] [Related]
12. Aspirin overcomes Navitoclax-resistance in hepatocellular carcinoma cells through suppression of Mcl-1.
Li G; Zhang S; Fang H; Yan B; Zhao Y; Feng L; Ma X; Ye X
Biochem Biophys Res Commun; 2013 May; 434(4):809-14. PubMed ID: 23611778
[TBL] [Abstract][Full Text] [Related]
13. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.
Taniai M; Grambihler A; Higuchi H; Werneburg N; Bronk SF; Farrugia DJ; Kaufmann SH; Gores GJ
Cancer Res; 2004 May; 64(10):3517-24. PubMed ID: 15150106
[TBL] [Abstract][Full Text] [Related]
14. Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax.
Sitia L; Bonizzi A; Mazzucchelli S; Negri S; Sottani C; Grignani E; Rizzuto MA; Prosperi D; Sorrentino L; Morasso C; Allevi R; Sevieri M; Silva F; Truffi M; Corsi F
Cells; 2021 Feb; 10(2):. PubMed ID: 33562504
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells.
Thongchot S; Ferraresi A; Vidoni C; Loilome W; Yongvanit P; Namwat N; Isidoro C
Cancer Lett; 2018 Aug; 430():160-171. PubMed ID: 29802929
[TBL] [Abstract][Full Text] [Related]
17. The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid.
Romani AA; Desenzani S; Morganti MM; Baroni MC; Borghetti AF; Soliani P
Cancer Chemother Pharmacol; 2011 Mar; 67(3):557-67. PubMed ID: 20473610
[TBL] [Abstract][Full Text] [Related]
18. Dynamic BH3 profiling identifies active BH3 mimetic combinations in non-small cell lung cancer.
Potter DS; Du R; Bhola P; Bueno R; Letai A
Cell Death Dis; 2021 Jul; 12(8):741. PubMed ID: 34315868
[TBL] [Abstract][Full Text] [Related]
19. A Bax-mediated mechanism for obatoclax-induced apoptosis of cholangiocarcinoma cells.
Smoot RL; Blechacz BR; Werneburg NW; Bronk SF; Sinicrope FA; Sirica AE; Gores GJ
Cancer Res; 2010 Mar; 70(5):1960-9. PubMed ID: 20160031
[TBL] [Abstract][Full Text] [Related]
20. Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma.
Ying F; Chan MSM; Lee TKW
Cell Mol Gastroenterol Hepatol; 2023; 15(4):985-999. PubMed ID: 36708970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]